Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
4,882
archived clinical trials in
Obesity Weight Loss

Effectiveness of the Optifast Program Compared With a Reduced-energy Food Based Diet Plan on Body Weight
Opti-WIN: Effectiveness of the Optifast Program Compared With a Reduced-energy Food Based Diet Plan on Body Weight
Status: Enrolling
Updated:  12/5/2016
Thomas Jefferson University
mi
from
Philadelphia, PA
Effectiveness of the Optifast Program Compared With a Reduced-energy Food Based Diet Plan on Body Weight
Opti-WIN: Effectiveness of the Optifast Program Compared With a Reduced-energy Food Based Diet Plan on Body Weight
Status: Enrolling
Updated: 12/5/2016
Thomas Jefferson University
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Effectiveness of the Optifast Program Compared With a Reduced-energy Food Based Diet Plan on Body Weight
Opti-WIN: Effectiveness of the Optifast Program Compared With a Reduced-energy Food Based Diet Plan on Body Weight
Status: Enrolling
Updated:  12/5/2016
Neuro-Behavioral Clinical Research, Inc.
mi
from
Canton, OH
Effectiveness of the Optifast Program Compared With a Reduced-energy Food Based Diet Plan on Body Weight
Opti-WIN: Effectiveness of the Optifast Program Compared With a Reduced-energy Food Based Diet Plan on Body Weight
Status: Enrolling
Updated: 12/5/2016
Neuro-Behavioral Clinical Research, Inc.
mi
from
Canton, OH
Click here to add this to my saved trials
Effectiveness of the Optifast Program Compared With a Reduced-energy Food Based Diet Plan on Body Weight
Opti-WIN: Effectiveness of the Optifast Program Compared With a Reduced-energy Food Based Diet Plan on Body Weight
Status: Enrolling
Updated:  12/5/2016
Houston Center for Clinical Research
mi
from
Sugarland, TX
Effectiveness of the Optifast Program Compared With a Reduced-energy Food Based Diet Plan on Body Weight
Opti-WIN: Effectiveness of the Optifast Program Compared With a Reduced-energy Food Based Diet Plan on Body Weight
Status: Enrolling
Updated: 12/5/2016
Houston Center for Clinical Research
mi
from
Sugarland, TX
Click here to add this to my saved trials
Testing Strategies for Weight Loss, II
Status: Enrolling
Updated:  12/5/2016
Philadelphia Veterans Administration Medical Center
mi
from
Philadelphia, PA
Testing Strategies for Weight Loss, II
Status: Enrolling
Updated: 12/5/2016
Philadelphia Veterans Administration Medical Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Auricular Acupuncture in the Treatment of Obesity
Auricular Acupuncture in the Treatment of Obesity: a Randomized, Placebo-controlled, Trial
Status: Enrolling
Updated:  12/8/2016
Mike O'Callaghan Federal Hospital/Nellis Air Force Base
mi
from
Las Vegas, NV
Auricular Acupuncture in the Treatment of Obesity
Auricular Acupuncture in the Treatment of Obesity: a Randomized, Placebo-controlled, Trial
Status: Enrolling
Updated: 12/8/2016
Mike O'Callaghan Federal Hospital/Nellis Air Force Base
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Prader-Willi Syndrome Macronutrient Study
Evidence-Based Approach to Dietary Management of Prader-Willi Syndrome (PWS)
Status: Enrolling
Updated:  12/13/2016
Duke Univ Med Ctr
mi
from
Durham, NC
Prader-Willi Syndrome Macronutrient Study
Evidence-Based Approach to Dietary Management of Prader-Willi Syndrome (PWS)
Status: Enrolling
Updated: 12/13/2016
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Prader-Willi Syndrome Macronutrient Study
Evidence-Based Approach to Dietary Management of Prader-Willi Syndrome (PWS)
Status: Enrolling
Updated:  12/13/2016
University of Alberta
mi
from
Edmonton,
Prader-Willi Syndrome Macronutrient Study
Evidence-Based Approach to Dietary Management of Prader-Willi Syndrome (PWS)
Status: Enrolling
Updated: 12/13/2016
University of Alberta
mi
from
Edmonton,
Click here to add this to my saved trials
Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Beloranib) in Obese Subjects With Prader-Willi Syndrome
Randomized, Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Subcutaneous Beloranib in Suspension) in Obese Subjects With Prader-Willi Syndrome to Evaluate Total Body Weight, Food-related Behavior, and Safety Over 6 Months
Status: Enrolling
Updated:  12/14/2016
University of California-Davis
mi
from
Sacramento, CA
Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Beloranib) in Obese Subjects With Prader-Willi Syndrome
Randomized, Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Subcutaneous Beloranib in Suspension) in Obese Subjects With Prader-Willi Syndrome to Evaluate Total Body Weight, Food-related Behavior, and Safety Over 6 Months
Status: Enrolling
Updated: 12/14/2016
University of California-Davis
mi
from
Sacramento, CA
Click here to add this to my saved trials
Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Beloranib) in Obese Subjects With Prader-Willi Syndrome
Randomized, Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Subcutaneous Beloranib in Suspension) in Obese Subjects With Prader-Willi Syndrome to Evaluate Total Body Weight, Food-related Behavior, and Safety Over 6 Months
Status: Enrolling
Updated:  12/14/2016
UCSD/Rady Childrens Hospital
mi
from
San Diego, CA
Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Beloranib) in Obese Subjects With Prader-Willi Syndrome
Randomized, Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Subcutaneous Beloranib in Suspension) in Obese Subjects With Prader-Willi Syndrome to Evaluate Total Body Weight, Food-related Behavior, and Safety Over 6 Months
Status: Enrolling
Updated: 12/14/2016
UCSD/Rady Childrens Hospital
mi
from
San Diego, CA
Click here to add this to my saved trials
Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Beloranib) in Obese Subjects With Prader-Willi Syndrome
Randomized, Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Subcutaneous Beloranib in Suspension) in Obese Subjects With Prader-Willi Syndrome to Evaluate Total Body Weight, Food-related Behavior, and Safety Over 6 Months
Status: Enrolling
Updated:  12/14/2016
Children's Hospital Colorado
mi
from
Aurora, CO
Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Beloranib) in Obese Subjects With Prader-Willi Syndrome
Randomized, Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Subcutaneous Beloranib in Suspension) in Obese Subjects With Prader-Willi Syndrome to Evaluate Total Body Weight, Food-related Behavior, and Safety Over 6 Months
Status: Enrolling
Updated: 12/14/2016
Children's Hospital Colorado
mi
from
Aurora, CO
Click here to add this to my saved trials
Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Beloranib) in Obese Subjects With Prader-Willi Syndrome
Randomized, Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Subcutaneous Beloranib in Suspension) in Obese Subjects With Prader-Willi Syndrome to Evaluate Total Body Weight, Food-related Behavior, and Safety Over 6 Months
Status: Enrolling
Updated:  12/14/2016
University of Florida
mi
from
Gainesville, FL
Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Beloranib) in Obese Subjects With Prader-Willi Syndrome
Randomized, Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Subcutaneous Beloranib in Suspension) in Obese Subjects With Prader-Willi Syndrome to Evaluate Total Body Weight, Food-related Behavior, and Safety Over 6 Months
Status: Enrolling
Updated: 12/14/2016
University of Florida
mi
from
Gainesville, FL
Click here to add this to my saved trials
Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Beloranib) in Obese Subjects With Prader-Willi Syndrome
Randomized, Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Subcutaneous Beloranib in Suspension) in Obese Subjects With Prader-Willi Syndrome to Evaluate Total Body Weight, Food-related Behavior, and Safety Over 6 Months
Status: Enrolling
Updated:  12/14/2016
Kansas University Medical Center
mi
from
Kansas City, KA
Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Beloranib) in Obese Subjects With Prader-Willi Syndrome
Randomized, Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Subcutaneous Beloranib in Suspension) in Obese Subjects With Prader-Willi Syndrome to Evaluate Total Body Weight, Food-related Behavior, and Safety Over 6 Months
Status: Enrolling
Updated: 12/14/2016
Kansas University Medical Center
mi
from
Kansas City, KA
Click here to add this to my saved trials
Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Beloranib) in Obese Subjects With Prader-Willi Syndrome
Randomized, Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Subcutaneous Beloranib in Suspension) in Obese Subjects With Prader-Willi Syndrome to Evaluate Total Body Weight, Food-related Behavior, and Safety Over 6 Months
Status: Enrolling
Updated:  12/14/2016
National Institute of Child Health
mi
from
Bethesda, MD
Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Beloranib) in Obese Subjects With Prader-Willi Syndrome
Randomized, Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Subcutaneous Beloranib in Suspension) in Obese Subjects With Prader-Willi Syndrome to Evaluate Total Body Weight, Food-related Behavior, and Safety Over 6 Months
Status: Enrolling
Updated: 12/14/2016
National Institute of Child Health
mi
from
Bethesda, MD
Click here to add this to my saved trials
Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Beloranib) in Obese Subjects With Prader-Willi Syndrome
Randomized, Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Subcutaneous Beloranib in Suspension) in Obese Subjects With Prader-Willi Syndrome to Evaluate Total Body Weight, Food-related Behavior, and Safety Over 6 Months
Status: Enrolling
Updated:  12/14/2016
Children's Hospital and Clinics of Minnesota
mi
from
St. Paul, MN
Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Beloranib) in Obese Subjects With Prader-Willi Syndrome
Randomized, Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Subcutaneous Beloranib in Suspension) in Obese Subjects With Prader-Willi Syndrome to Evaluate Total Body Weight, Food-related Behavior, and Safety Over 6 Months
Status: Enrolling
Updated: 12/14/2016
Children's Hospital and Clinics of Minnesota
mi
from
St. Paul, MN
Click here to add this to my saved trials
Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Beloranib) in Obese Subjects With Prader-Willi Syndrome
Randomized, Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Subcutaneous Beloranib in Suspension) in Obese Subjects With Prader-Willi Syndrome to Evaluate Total Body Weight, Food-related Behavior, and Safety Over 6 Months
Status: Enrolling
Updated:  12/14/2016
Saint Louis University
mi
from
St. Louis, MO
Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Beloranib) in Obese Subjects With Prader-Willi Syndrome
Randomized, Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Subcutaneous Beloranib in Suspension) in Obese Subjects With Prader-Willi Syndrome to Evaluate Total Body Weight, Food-related Behavior, and Safety Over 6 Months
Status: Enrolling
Updated: 12/14/2016
Saint Louis University
mi
from
St. Louis, MO
Click here to add this to my saved trials
Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Beloranib) in Obese Subjects With Prader-Willi Syndrome
Randomized, Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Subcutaneous Beloranib in Suspension) in Obese Subjects With Prader-Willi Syndrome to Evaluate Total Body Weight, Food-related Behavior, and Safety Over 6 Months
Status: Enrolling
Updated:  12/14/2016
Winthrop University
mi
from
Mineola, NY
Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Beloranib) in Obese Subjects With Prader-Willi Syndrome
Randomized, Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Subcutaneous Beloranib in Suspension) in Obese Subjects With Prader-Willi Syndrome to Evaluate Total Body Weight, Food-related Behavior, and Safety Over 6 Months
Status: Enrolling
Updated: 12/14/2016
Winthrop University
mi
from
Mineola, NY
Click here to add this to my saved trials
Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Beloranib) in Obese Subjects With Prader-Willi Syndrome
Randomized, Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Subcutaneous Beloranib in Suspension) in Obese Subjects With Prader-Willi Syndrome to Evaluate Total Body Weight, Food-related Behavior, and Safety Over 6 Months
Status: Enrolling
Updated:  12/14/2016
Vanderbilt University
mi
from
Nashville, TN
Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Beloranib) in Obese Subjects With Prader-Willi Syndrome
Randomized, Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Subcutaneous Beloranib in Suspension) in Obese Subjects With Prader-Willi Syndrome to Evaluate Total Body Weight, Food-related Behavior, and Safety Over 6 Months
Status: Enrolling
Updated: 12/14/2016
Vanderbilt University
mi
from
Nashville, TN
Click here to add this to my saved trials
Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Beloranib) in Obese Subjects With Prader-Willi Syndrome
Randomized, Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Subcutaneous Beloranib in Suspension) in Obese Subjects With Prader-Willi Syndrome to Evaluate Total Body Weight, Food-related Behavior, and Safety Over 6 Months
Status: Enrolling
Updated:  12/14/2016
Texas Children's Hospital
mi
from
Houston, TX
Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Beloranib) in Obese Subjects With Prader-Willi Syndrome
Randomized, Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Subcutaneous Beloranib in Suspension) in Obese Subjects With Prader-Willi Syndrome to Evaluate Total Body Weight, Food-related Behavior, and Safety Over 6 Months
Status: Enrolling
Updated: 12/14/2016
Texas Children's Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Beloranib) in Obese Subjects With Prader-Willi Syndrome
Randomized, Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Subcutaneous Beloranib in Suspension) in Obese Subjects With Prader-Willi Syndrome to Evaluate Total Body Weight, Food-related Behavior, and Safety Over 6 Months
Status: Enrolling
Updated:  12/14/2016
University of Utah
mi
from
Salt Lake City, UT
Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Beloranib) in Obese Subjects With Prader-Willi Syndrome
Randomized, Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Subcutaneous Beloranib in Suspension) in Obese Subjects With Prader-Willi Syndrome to Evaluate Total Body Weight, Food-related Behavior, and Safety Over 6 Months
Status: Enrolling
Updated: 12/14/2016
University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Beloranib) in Obese Subjects With Prader-Willi Syndrome
Randomized, Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Subcutaneous Beloranib in Suspension) in Obese Subjects With Prader-Willi Syndrome to Evaluate Total Body Weight, Food-related Behavior, and Safety Over 6 Months
Status: Enrolling
Updated:  12/14/2016
Seattle Children'S Research Institute
mi
from
Seattle, WA
Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Beloranib) in Obese Subjects With Prader-Willi Syndrome
Randomized, Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Subcutaneous Beloranib in Suspension) in Obese Subjects With Prader-Willi Syndrome to Evaluate Total Body Weight, Food-related Behavior, and Safety Over 6 Months
Status: Enrolling
Updated: 12/14/2016
Seattle Children'S Research Institute
mi
from
Seattle, WA
Click here to add this to my saved trials
Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Beloranib) in Obese Subjects With Prader-Willi Syndrome
Randomized, Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Subcutaneous Beloranib in Suspension) in Obese Subjects With Prader-Willi Syndrome to Evaluate Total Body Weight, Food-related Behavior, and Safety Over 6 Months
Status: Enrolling
Updated:  12/14/2016
Children's Hospital Boston
mi
from
Boston, MA
Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Beloranib) in Obese Subjects With Prader-Willi Syndrome
Randomized, Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Subcutaneous Beloranib in Suspension) in Obese Subjects With Prader-Willi Syndrome to Evaluate Total Body Weight, Food-related Behavior, and Safety Over 6 Months
Status: Enrolling
Updated: 12/14/2016
Children's Hospital Boston
mi
from
Boston, MA
Click here to add this to my saved trials
Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Beloranib) in Obese Subjects With Prader-Willi Syndrome
Randomized, Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Subcutaneous Beloranib in Suspension) in Obese Subjects With Prader-Willi Syndrome to Evaluate Total Body Weight, Food-related Behavior, and Safety Over 6 Months
Status: Enrolling
Updated:  12/14/2016
University Hospitals at Case Medical Center
mi
from
Cleveland, OH
Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Beloranib) in Obese Subjects With Prader-Willi Syndrome
Randomized, Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Subcutaneous Beloranib in Suspension) in Obese Subjects With Prader-Willi Syndrome to Evaluate Total Body Weight, Food-related Behavior, and Safety Over 6 Months
Status: Enrolling
Updated: 12/14/2016
University Hospitals at Case Medical Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Behavioral Weight Loss as a Treatment for Migraine in Obese Women
Behavioral Weight Loss as a Treatment for Migraine in Obese Women
Status: Enrolling
Updated:  12/20/2016
The Miriam Hospital Weight Control and Diabetes Research Center
mi
from
Providence, RI
Behavioral Weight Loss as a Treatment for Migraine in Obese Women
Behavioral Weight Loss as a Treatment for Migraine in Obese Women
Status: Enrolling
Updated: 12/20/2016
The Miriam Hospital Weight Control and Diabetes Research Center
mi
from
Providence, RI
Click here to add this to my saved trials
MPOWERed Messages: Tailored Mobile Messages to Enhance Weight Loss for Teens
Novel Individually Tailored Mobile Messages to Enhance Weight Loss for Teens
Status: Enrolling
Updated:  12/20/2016
University of Michigan
mi
from
Ann Arbor, MI
MPOWERed Messages: Tailored Mobile Messages to Enhance Weight Loss for Teens
Novel Individually Tailored Mobile Messages to Enhance Weight Loss for Teens
Status: Enrolling
Updated: 12/20/2016
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Safety, Efficacy, Tolerability and Pharmacokinetics of NNC 0070-0002-0182 in Overweight or Obese Male and Female Volunteers
Safety, Efficacy, Tolerability and Pharmacokinetics of NNC 0070-0002-0182 in Overweight or Obese Healthy Male and Female Volunteers
Status: Enrolling
Updated:  12/22/2016
Novo Nordisk Investigational Site
mi
from
Evansville, IN
Safety, Efficacy, Tolerability and Pharmacokinetics of NNC 0070-0002-0182 in Overweight or Obese Male and Female Volunteers
Safety, Efficacy, Tolerability and Pharmacokinetics of NNC 0070-0002-0182 in Overweight or Obese Healthy Male and Female Volunteers
Status: Enrolling
Updated: 12/22/2016
Novo Nordisk Investigational Site
mi
from
Evansville, IN
Click here to add this to my saved trials
Safety, Efficacy, Tolerability and Pharmacokinetics of NNC 0070-0002-0182 in Overweight or Obese Male and Female Volunteers
Safety, Efficacy, Tolerability and Pharmacokinetics of NNC 0070-0002-0182 in Overweight or Obese Healthy Male and Female Volunteers
Status: Enrolling
Updated:  12/22/2016
Novo Nordisk Investigational Site
mi
from
Madison, WI
Safety, Efficacy, Tolerability and Pharmacokinetics of NNC 0070-0002-0182 in Overweight or Obese Male and Female Volunteers
Safety, Efficacy, Tolerability and Pharmacokinetics of NNC 0070-0002-0182 in Overweight or Obese Healthy Male and Female Volunteers
Status: Enrolling
Updated: 12/22/2016
Novo Nordisk Investigational Site
mi
from
Madison, WI
Click here to add this to my saved trials
Behavioral Treatment for Obese Preschoolers
Clinic and Home Family Based Behavioral Treatment for Obese Preschoolers
Status: Enrolling
Updated:  12/27/2016
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Behavioral Treatment for Obese Preschoolers
Clinic and Home Family Based Behavioral Treatment for Obese Preschoolers
Status: Enrolling
Updated: 12/27/2016
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Effect of Meal Number, Frequency, and Form on Satiety and Metabolism After Weight Loss Surgery
Effect of Meal Number, Frequency, and Form on Satiety and Metabolism After Weight Loss Surgery
Status: Enrolling
Updated:  12/28/2016
St. Lukes- Roosevelt Hospital- New York Obesity Research Center
mi
from
New York, NY
Effect of Meal Number, Frequency, and Form on Satiety and Metabolism After Weight Loss Surgery
Effect of Meal Number, Frequency, and Form on Satiety and Metabolism After Weight Loss Surgery
Status: Enrolling
Updated: 12/28/2016
St. Lukes- Roosevelt Hospital- New York Obesity Research Center
mi
from
New York, NY
Click here to add this to my saved trials
Pathophysiology of Cardiometabolic Risk Factors in African Americans
Obesity, Hypertension in African American Women, Neuro-metabolic Mechanism
Status: Enrolling
Updated:  12/29/2016
Vanderbilt University
mi
from
Nashville, TN
Pathophysiology of Cardiometabolic Risk Factors in African Americans
Obesity, Hypertension in African American Women, Neuro-metabolic Mechanism
Status: Enrolling
Updated: 12/29/2016
Vanderbilt University
mi
from
Nashville, TN
Click here to add this to my saved trials
Metabolic and Cardiovascular Impact of CD36 Deficiency in African Americans
Metabolic and Cardiovascular Impact of CD36 Deficiency in African Americans
Status: Enrolling
Updated:  12/29/2016
Vanderbilt University
mi
from
Nashville, TN
Metabolic and Cardiovascular Impact of CD36 Deficiency in African Americans
Metabolic and Cardiovascular Impact of CD36 Deficiency in African Americans
Status: Enrolling
Updated: 12/29/2016
Vanderbilt University
mi
from
Nashville, TN
Click here to add this to my saved trials
Sleep Plus Eating Routines for Weight Loss
Increasing Sleep Duration: A Novel Approach to Weight Control. Study 5-Randomized Trial of Sleep Plus Eating Routines as An Approach to Prepare Participants for Weight Loss
Status: Enrolling
Updated:  1/3/2017
Weight Control and Diabetes Research Center
mi
from
Providence, RI
Sleep Plus Eating Routines for Weight Loss
Increasing Sleep Duration: A Novel Approach to Weight Control. Study 5-Randomized Trial of Sleep Plus Eating Routines as An Approach to Prepare Participants for Weight Loss
Status: Enrolling
Updated: 1/3/2017
Weight Control and Diabetes Research Center
mi
from
Providence, RI
Click here to add this to my saved trials
Calcium Supplementation for a Healthy Weight-Lite (CaSHeW Lite)
Calcium Supplementation for a Healthy Weight- LITE
Status: Enrolling
Updated:  1/9/2017
Massachusetts General Hospital Weight Center
mi
from
Boston, MA
Calcium Supplementation for a Healthy Weight-Lite (CaSHeW Lite)
Calcium Supplementation for a Healthy Weight- LITE
Status: Enrolling
Updated: 1/9/2017
Massachusetts General Hospital Weight Center
mi
from
Boston, MA
Click here to add this to my saved trials
A Study To Investigate The Safety And Metabolism Of GSK376501 In Overweight Subjects
A Single-Blind, Randomized, Placebo Controlled, Ascending Single and Repeat Dose Study With Once Daily Dosing to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GSK376501 and to Evaluate Food Effects and the Relative Bioavailability of a Tablet Formulation Compared to the Powder for Reconstitution Formulation in Healthy Overweight and Obese Subjects (DIX109177)
Status: Enrolling
Updated:  1/18/2017
GSK Investigational Site
mi
from
Evansville, IN
A Study To Investigate The Safety And Metabolism Of GSK376501 In Overweight Subjects
A Single-Blind, Randomized, Placebo Controlled, Ascending Single and Repeat Dose Study With Once Daily Dosing to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GSK376501 and to Evaluate Food Effects and the Relative Bioavailability of a Tablet Formulation Compared to the Powder for Reconstitution Formulation in Healthy Overweight and Obese Subjects (DIX109177)
Status: Enrolling
Updated: 1/18/2017
GSK Investigational Site
mi
from
Evansville, IN
Click here to add this to my saved trials
Lifestyle Intervention Trial in Obese Elderly
Exercise Interventions During Voluntary Weight Loss in Obese Older Adults
Status: Enrolling
Updated:  1/25/2017
New Mexico VA Medical Center and University of New Mexico School of Medicine
mi
from
Albuquerque, NM
Lifestyle Intervention Trial in Obese Elderly
Exercise Interventions During Voluntary Weight Loss in Obese Older Adults
Status: Enrolling
Updated: 1/25/2017
New Mexico VA Medical Center and University of New Mexico School of Medicine
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Lifestyle Intervention Trial in Obese Elderly
Exercise Interventions During Voluntary Weight Loss in Obese Older Adults
Status: Enrolling
Updated:  1/25/2017
Baylor College of Medicine
mi
from
Houston, TX
Lifestyle Intervention Trial in Obese Elderly
Exercise Interventions During Voluntary Weight Loss in Obese Older Adults
Status: Enrolling
Updated: 1/25/2017
Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
mHealth Messages to Sustain Recent Weight Loss - Phase 2
Mobile Health Messages to Sustain Recent Weight Loss - Phase 2
Status: Enrolling
Updated:  1/25/2017
Duke University Medical Center, Diet and Fitness Center
mi
from
Durham, NC
mHealth Messages to Sustain Recent Weight Loss - Phase 2
Mobile Health Messages to Sustain Recent Weight Loss - Phase 2
Status: Enrolling
Updated: 1/25/2017
Duke University Medical Center, Diet and Fitness Center
mi
from
Durham, NC
Click here to add this to my saved trials
A Study to Examine Changes in GIP Plasma Levels Following Gastric Bypass Surgery in Obese Patients
A Pilot Study to Examine the Relationship Between Changes in Plasma GIP Levels and Other Gastrointestinal Peptides Following Gastric Bypass Surgery in Obese Patients
Status: Enrolling
Updated:  1/25/2017
Boston University Medical Center
mi
from
Boston, MA
A Study to Examine Changes in GIP Plasma Levels Following Gastric Bypass Surgery in Obese Patients
A Pilot Study to Examine the Relationship Between Changes in Plasma GIP Levels and Other Gastrointestinal Peptides Following Gastric Bypass Surgery in Obese Patients
Status: Enrolling
Updated: 1/25/2017
Boston University Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Development of Melt Organic Baking Fat for Reducing Child Obesity
Development and Expansion of Melt Organic Baking Fat for Oxidative Stability and Reducing Child Obesity
Status: Enrolling
Updated:  1/30/2017
New York Nutrition Obesity Research Center
mi
from
New York, NY
Development of Melt Organic Baking Fat for Reducing Child Obesity
Development and Expansion of Melt Organic Baking Fat for Oxidative Stability and Reducing Child Obesity
Status: Enrolling
Updated: 1/30/2017
New York Nutrition Obesity Research Center
mi
from
New York, NY
Click here to add this to my saved trials
Sutures vs. Staples Skin Closure After C-section in Obese Patients
Staples Compared With Subcuticular Suture for Skin Closure After Cesarean Delivery in Obese Patients
Status: Enrolling
Updated:  2/2/2017
University of Arkansas for Medical Sciences
mi
from
Little Rock, AR
Sutures vs. Staples Skin Closure After C-section in Obese Patients
Staples Compared With Subcuticular Suture for Skin Closure After Cesarean Delivery in Obese Patients
Status: Enrolling
Updated: 2/2/2017
University of Arkansas for Medical Sciences
mi
from
Little Rock, AR
Click here to add this to my saved trials
Assessing Inherited Markers of Metabolic Syndrome in the Young
Assessing Inherited Markers of Metabolic Syndrome in the Young
Status: Enrolling
Updated:  2/8/2017
Childrens National Medical Center
mi
from
Washington,
Assessing Inherited Markers of Metabolic Syndrome in the Young
Assessing Inherited Markers of Metabolic Syndrome in the Young
Status: Enrolling
Updated: 2/8/2017
Childrens National Medical Center
mi
from
Washington,
Click here to add this to my saved trials
Vitamin D Supplementation in Overweight/Obese African American Adults and Youth (D-SUNNY)
Vitamin D Supplementation in Overweight/Obese African American Adults and Youth (D-SUNNY)
Status: Enrolling
Updated:  2/8/2017
Georgia Prevention Institute
mi
from
Augusta, GA
Vitamin D Supplementation in Overweight/Obese African American Adults and Youth (D-SUNNY)
Vitamin D Supplementation in Overweight/Obese African American Adults and Youth (D-SUNNY)
Status: Enrolling
Updated: 2/8/2017
Georgia Prevention Institute
mi
from
Augusta, GA
Click here to add this to my saved trials
Prophylactic Use of Enoxaparin in Morbidly Obese Adolescents During Bariatric Surgery
Prophylactic Use of Enoxaparin in Morbidly Obese Adolescents During Bariatric Surgery
Status: Enrolling
Updated:  2/9/2017
Childrens National Medical Center
mi
from
Washington,
Prophylactic Use of Enoxaparin in Morbidly Obese Adolescents During Bariatric Surgery
Prophylactic Use of Enoxaparin in Morbidly Obese Adolescents During Bariatric Surgery
Status: Enrolling
Updated: 2/9/2017
Childrens National Medical Center
mi
from
Washington,
Click here to add this to my saved trials
Soda and Milk Study
Effects of Replacing Sugar Sweetened Beverages With Milk on Metabolic Factors in Overweight and Obese Adolescents
Status: Enrolling
Updated:  2/14/2017
Cholesterol Research Center
mi
from
Berkeley, CA
Soda and Milk Study
Effects of Replacing Sugar Sweetened Beverages With Milk on Metabolic Factors in Overweight and Obese Adolescents
Status: Enrolling
Updated: 2/14/2017
Cholesterol Research Center
mi
from
Berkeley, CA
Click here to add this to my saved trials
Energy Balance and Weight Gain With Ivacaftor Treatment
Energy Balance and Weight Gain With Ivacaftor Treatment of CFTR Gating Mutations
Status: Enrolling
Updated:  2/16/2017
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Energy Balance and Weight Gain With Ivacaftor Treatment
Energy Balance and Weight Gain With Ivacaftor Treatment of CFTR Gating Mutations
Status: Enrolling
Updated: 2/16/2017
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Lose Now North Carolina Community Weight Loss Program
Lose-Now-NC: Feasibility of a Large Group Format Community Weight Loss Program Coupled With Internet Support
Status: Enrolling
Updated:  2/23/2017
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Lose Now North Carolina Community Weight Loss Program
Lose-Now-NC: Feasibility of a Large Group Format Community Weight Loss Program Coupled With Internet Support
Status: Enrolling
Updated: 2/23/2017
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Evaluation of Intra-Abdominal Fat in Patients With Type 2 Diabetes Using a Non-Invasive Method
Evaluation of Intra-Abdominal Fat Contents in Patients With Type 2 Diabetes Using a Novel Non-Invasive Method of Bioelectric Impedance
Status: Enrolling
Updated:  2/28/2017
Joslin Diabetes Center
mi
from
Boston, MA
Evaluation of Intra-Abdominal Fat in Patients With Type 2 Diabetes Using a Non-Invasive Method
Evaluation of Intra-Abdominal Fat Contents in Patients With Type 2 Diabetes Using a Novel Non-Invasive Method of Bioelectric Impedance
Status: Enrolling
Updated: 2/28/2017
Joslin Diabetes Center
mi
from
Boston, MA
Click here to add this to my saved trials
The Effect of add-on Canagliflozin in Patients With Type 2 Diabetes Treated With U-500 Insulin
The Effect of add-on Canagliflozin in Patients With Type 2 Diabetes Treated With ≥200 Units Per Day of U-500 Insulin
Status: Enrolling
Updated:  2/28/2017
Joslin Diabetes Center
mi
from
Boston, MA
The Effect of add-on Canagliflozin in Patients With Type 2 Diabetes Treated With U-500 Insulin
The Effect of add-on Canagliflozin in Patients With Type 2 Diabetes Treated With ≥200 Units Per Day of U-500 Insulin
Status: Enrolling
Updated: 2/28/2017
Joslin Diabetes Center
mi
from
Boston, MA
Click here to add this to my saved trials
Mediterranean Diet and Protein-Sparing Modified Diet for Metabolic Syndrome in Liver Transplant Recipients
The Safety and Efficacy of Mediterranean Diet and Protein-Sparing Modified Diet on Obesity and Metabolic Syndrome in Liver Transplant Recipients: A Randomized Clinical Trial
Status: Enrolling
Updated:  3/13/2017
Cleveland Clinic
mi
from
Cleveland, OH
Mediterranean Diet and Protein-Sparing Modified Diet for Metabolic Syndrome in Liver Transplant Recipients
The Safety and Efficacy of Mediterranean Diet and Protein-Sparing Modified Diet on Obesity and Metabolic Syndrome in Liver Transplant Recipients: A Randomized Clinical Trial
Status: Enrolling
Updated: 3/13/2017
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
Preventing Obesity in the Worksite: A Multi-Message, Multi-"Step" Approach
Preventing Obesity in the Worksite: A Multi-Message, Multi-"Step" Approach
Status: Enrolling
Updated:  3/13/2017
St. Luke's Hospital and Clinics
mi
from
Duluth, MN
Preventing Obesity in the Worksite: A Multi-Message, Multi-"Step" Approach
Preventing Obesity in the Worksite: A Multi-Message, Multi-"Step" Approach
Status: Enrolling
Updated: 3/13/2017
St. Luke's Hospital and Clinics
mi
from
Duluth, MN
Click here to add this to my saved trials
Mass in Motion Kids in the Clinical Setting
MA Childhood Obesity Research Demonstration (CORD) Project
Status: Enrolling
Updated:  3/21/2017
Community Health Connections, Inc.
mi
from
Fitchburg, MA
Mass in Motion Kids in the Clinical Setting
MA Childhood Obesity Research Demonstration (CORD) Project
Status: Enrolling
Updated: 3/21/2017
Community Health Connections, Inc.
mi
from
Fitchburg, MA
Click here to add this to my saved trials